Health
Experimental compound strengthens mouse bones by activating key receptor
Stimulating the GPR133 receptor builds bone density in mice, ScienceDaily reports.
The short version
- Leipzig University researchers found that the experimental compound AP503 significantly increased bone strength in mice.[ScienceDaily]
- The compound activates the GPR133 receptor, boosting bone-forming osteoblasts while slowing bone-resorbing osteoclasts.[ScienceDaily]
- Prior work indicates AP503 also strengthens skeletal muscle, though human applications remain to be investigated in follow-up research.[ScienceDaily]
Key facts
- Leipzig University researchers found that compound AP503 strengthens bones in mice by targeting the GPR133 receptor.[ScienceDaily]
- Stimulating GPR133 encourages the activity of bone-building osteoblasts and suppresses bone-resorbing osteoclasts.[ScienceDaily]
- Mice with genetically impaired GPR133 exhibit early loss of bone density comparable to human osteoporosis.[ScienceDaily]
- An earlier study by the research team showed that AP503 activation also strengthens skeletal muscle.[ScienceDaily]
What remains uncertain
- The findings are limited to animal models, and clinical efficacy or safety in humans has not yet been demonstrated.[ScienceDaily]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.
- Scientists find a bone-building switch that could fight osteoporosisScienceDaily - Science